Fulcrum Therapeutics FULC
NASDAQ FULC
$3.70 -0.02 (-0.54%)
At close: Oct 21, 2026 · 4:00 PM EDT

Fulcrum Therapeutics (FULC) Restructuring Costs (2022 - 2026)

Updated

Fulcrum Therapeutics (FULC) reported Restructuring Costs of $4.32 million for Q2 2026.

Analysis

Fulcrum Therapeutics (FULC) Restructuring Costs (2022 - 2026) Analysis & Trends

For FY2024, Fulcrum Therapeutics posted Restructuring Costs of $2.06 million.

  • By year, Restructuring Costs came in at $427,000 in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly Restructuring Costs since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Fulcrum Therapeutics 282.94 Mn -60.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.32 Mn
Sep 30, 2024 2.06 Mn
Dec 31, 2022 -38,000.00
Sep 30, 2022 465,000.00
API Access

Fulcrum Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=FULC&period=max&api_key=YOUR_API_KEY